{
  "text": "Treatment of drug-induced agranulocytosis with recombinant GM-CSF \n A 53-year male patient, treated for rheumatoid arthritis with sulphasalazine, developed a total agranulocytosis.\n When this state had prevailed for at least 10 d no bone marrow granulocyte progenitor cells were detectable.\n Intravenous GM-CSF treatment was initiated 5 d later, and the patient recovered within the next 6 d.\n GM-CSF treatment for severe agranulocytosis deserves further investigation.",
  "category": "C15"
}